Objectives: To evaluate the cost-effectiveness and surgical efficacy of intraoperative cell saver use in lumbar degenerative scoliosis surgery.

Methods: 50 lumbar degenerative scoliosis patients who underwent instrumentation, fusion and correction with a posterior approach were analyzed. Patients were formed as cell saver (CS group, n: 26) and non-cell saver (NCS group, n: 24). Between groups, instrumentation- osteotomy levels, and cost effectiveness assessment were performed.

Results: The number of instrumentation levels is 5.07 ± 1.89 in group CS, 3.6 ± 1.88 in group NCS (p = 0.004); the number of osteotomy levels was 2.84 ± 1.51 in group CS and 1.83 ± 0.91 in group NCS (p = 0.007). Cost effectiveness analysis was evaluated; In CS, the total cost was found to be 42010.4 ± 27700 $, while the group NCS was 17105 ± 18220.6 $ (p = 0.001).

Conclusion: The use of cell saver is not routinely required in lumbar degenerative scoliosis surgery. Despite its high cost, it may be useful in cases where instrumentation-osteotomy levels are high.